SproutNews logo

Global Biopharmaceuticals Market: Asian Is Expected to Witness Fastest Growth Globally during 2015 – 2020 By P&S Market Research

The global biopharmaceuticals market was valued at $ 160,440.4 million in 2014, and it is expected to grow with a CAGR of 9.6% during the period 2015 – 2020. The global biopharmaceuticals market is increasing, due to growing aging population. In addition, the increasing healthcare investments around the world are propelling the increase in R&D investments, which is fuelling the growth of the global biopharmaceuticals market.

Furthermore, the increasing prevalence of chronic diseases due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity is also contributing to the growth in demand of biopharmaceuticals globally. On the basis of types, the global recombinant human insulin market segment is expected to witness fastest growth during the forecast period. Among the application segment, the oncology segment accounted for the largest market in the global biopharmaceuticals market in 2014; and is expected to witness fastest growth, with 11.1% CAGR during the period 2015 – 2020.

Explore Report with Detailed TOC on “Global Biopharmaceuticals Market” at:
https://www.psmarketresearch.com/market-analysis/biopharmaceuticals-market

The information and data in the publication “Global Biopharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Monoclonal Antibodies, Recombinant Proteins, Interferon, Colony-Stimulating Factor, Erythropoietin, Recombinant Human Insulin, Vaccines, Growth Hormones, Purified Proteins and others) and by Application (Oncology, Inflammatory and Infectious Diseases, Metabolic disorders, Neurological Disorders, Cardiovascular Diseases and others)” represent the research and analysis of data from various primary and secondary sources. The bottom-up approach has been used to calculate the global biopharmaceuticals market size by type and application. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

Download Sample Pages at:
https://www.psmarketresearch.com/market-analysis/biopharmaceuticals-market/report-sample

This research offers actual historical market size (2011 – 2014) and forecast (2015 – 2020) of the global biopharmaceuticals market in the U.S. dollars.

GLOBAL BIOPHARMACEUTICALS MARKET


GLOBAL BIOPHARMACEUTICALS MARKET, BY TYPE


About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Web: https://www.psmarketresearch.com

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2016/01/1452765569.jpeg

Media Contact
Company Name: P&S Market Research
Contact Person: Abhishek, Executive – Client Partner
Email: enquiry@psmarketresearch.com
Phone: +1-888-778-7886 (USA/Canada Toll-Free)
Address:347, 5th Ave. #1402
City: New York City
State: NY
Country: United States
Website: https://www.psmarketresearch.com

Source: ABNewswire

ReleaseID: 49070

Go Top